MEVOX LTD
Company number 12284441 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£3,121,351
Balance sheet as at 2025-10-31
What it does
The principal activity of the company is that of vaccine innovation.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-10-28
- Employees
- 4 (2025 accounts · was 3 in 2024)
- Registered office
- Regent House, 316a Beulah Hill, London, United Kingdom, United Kingdom, SE19 3HF
- Postcode
- SE19 3HF
- Capital
- 16 GBP
- Accounts category
- Unaudited Abridged
Accounts
- Last made up to
- 2025-10-31
- Next due by
- 2027-07-31
- Financial year end
- 31 October
Confirmation statement
- Last statement dated
- 2025-10-27
- Next due by
- 2026-11-10
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 6 current · 2 resigned
Subscribers only
Director
Subscribers only
Director
Subscribers only
Corporate Secretary
Subscribers only
Director
Subscribers only
Director
Previous registered addresses 1
| Address | Changed on |
|---|---|
| UPFIELD LEAMINGTON ROAD, PRINCETHORPE, RUGBY, CV23 9PU, ENGLAND | 2021-04-15 |
Competitors London
-
3. BACTOBIO LTD
This company ranks 44 among research and experimental development on biotechnology in London.
The class of 2019
38%
of the 499 companies in this sector incorporated in 2019 are still active today; 58% have since been dissolved.
A fact about the year, not a forecast for this company.